Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of Chemotherapy Rechallenge Versus Regorafenib or Trifluridine/Tipiracil in Third-Line Setting of Metastatic Colorectal Cancer: A Multicenter Retrospective Comparative Study.
Bazarbashi S, Alkhatib R, Aseafan M, Tuleimat Y, Abdel-Aziz N, Mahrous M, Elsamany S, Elhassan T, Alghamdi M. Bazarbashi S, et al. Among authors: elsamany s. JCO Glob Oncol. 2024 Mar;10:e2300461. doi: 10.1200/GO.23.00461. JCO Glob Oncol. 2024. PMID: 38484194 Free PMC article.
Hormonal-Receptors-Positive and HER2-Negative Patients with Metastatic Breast Cancer Treated with First-Line Palbociclib and Hormonal Therapy: Impact of First-Cycle Neutropenia and Dose Reduction on Therapeutic Outcome.
Elnaghi KAEA, Alghanmi HA, Elsamany SA, Almarzoki F, Elsafty M, Jaffal M. Elnaghi KAEA, et al. Among authors: elsamany sa. Breast J. 2023 Aug 25;2023:8994954. doi: 10.1155/2023/8994954. eCollection 2023. Breast J. 2023. PMID: 37664544 Free PMC article.
Outcomes of Patients with Metastatic Colorectal Cancer Treated with Trifluridine/Tipiracil beyond the Second Line: A Multicenter Retrospective Study from Saudi Arabia.
Alghamdi M, Bazarbashi S, Mahrous M, Alshaer O, Mostafa Gad A, Aseafan M, Abdelgelil M, Alshabi RM, Alghanmi HA, Naser NA, Al Hariri H, ALHamad A, Al-Saleh K, Abdel-Aziz N, Elsamany S. Alghamdi M, et al. Among authors: elsamany s. J Oncol. 2022 Sep 12;2022:3796783. doi: 10.1155/2022/3796783. eCollection 2022. J Oncol. 2022. PMID: 36147443 Free PMC article.
Profiling Activins and Follistatin in Colorectal Cancer According to Clinical Stage, Tumour Sidedness and Smad4 Status.
Refaat B, Zekri J, Aslam A, Ahmad J, Baghdadi MA, Meliti A, Idris S, Sultan S, Alardati H, Saimeh HA, Alsaegh A, Alhadrami M, Hamid T, Naeem ME, Elsamany SA. Refaat B, et al. Among authors: elsamany sa. Pathol Oncol Res. 2021 Nov 15;27:1610032. doi: 10.3389/pore.2021.1610032. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34867090 Free PMC article.
Optimizing the Communication with Cancer Patients During the COVID-19 Pandemic: Patient Perspectives.
Tashkandi E, BaAbdullah M, Zeeneldin A, AlAbdulwahab A, Elemam O, Elsamany S, Alfayez M, Dabash Y, Khayat E, Hassanin F, Abdulhameed R, Jazieh AR. Tashkandi E, et al. Among authors: elsamany s. Patient Prefer Adherence. 2020 Jul 20;14:1205-1212. doi: 10.2147/PPA.S263022. eCollection 2020. Patient Prefer Adherence. 2020. PMID: 32764893 Free PMC article.
23 results